Hit enter to search or ESC to close
YOZMA GROUP KOREAYOZMA GROUP KOREA
Menu
  • About
    • Overview
    • Our Team
  • Business
    • Investment
    • Accelerator
    • Consulting
    • Tech Transfer
  • Campus
    • Overview
    • Partners
    • Portfolio
  • Portfolio
  • Newsroom
    • News
    • Press Release
    • Video
  • Contact
    • Recruit
  • English
    • Korean
  • About
    • Overview
    • Our Team
  • Business
    • Investment
    • Accelerator
    • Consulting
    • Tech Transfer
  • Campus
    • Overview
    • Partners
    • Portfolio
  • Portfolio
  • Newsroom
    • News
    • Press Release
    • Video
  • Contact
    • Recruit
  • English
    • Korean
UltraSight Receives CE Mark for Novel Cardiac AI Technology
News

UltraSight Receives CE Mark for Novel Cardiac AI Technology

By 관리정경단2022-08-25September 2nd, 2022No Comments

Home » UltraSight Receives CE Mark for Novel Cardiac AI Technology

UltraSight Receives CE Mark for Novel Cardiac AI Technology

https://www.prnewswire.com/news-releases/ultrasight-receives-ce-mark-for-novel-cardiac-ai-technology-301610619.html
  • Previous PostUltraSight Receives CE Mark for Cardiac Ultrasound AI Guidence

  • Next PostAlpha Tau, "Cancer Treatment with Alpha Radiation aims to conduct clinical trials in Korea"

Seoul Office
9F, 457, Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea
t. +82 2 6949 5350
e. [email protected]

Israel Office
2 Ben Gurion way, BSR 1 building fl 14, Ramat Gan, Israel
e. [email protected]

Family Site →
  • Privacy Policy

© 2025 Yozma Group Korea.